Research Article: The Role of Neutrophil-to-Lymphocyte Ratio in Advanced EGFR-Mutant NSCLC Patients Treated with First-Line Osimertinib
Introduction:
Lung cancer carries both a high incidence and a high mortality rate, and is the leading cause of cancer-related death worldwide. Epidermal growth factor receptor ( EGFR ) mutation is the most common genetic alteration among East Asian people with non-small cell lung cancer (NSCLC). Given the higher response rate, longer survival time, and better quality of life, EGFR-TKIs have emerged as the cornerstone therapy for advanced NSCLC patients harboring sensitizing EGFR mutations and are recommended as the standard…
Read more